Trace Your Case


Whether Cipla’s product, ‘Erlocip’ which is Polymorph B of the compound ‘Erlotinib’ encroaches Roche’s patented compound ‘Erlotinib’.

Whether Roche’s patented compound ‘Erlotinib’ is a legitimate patent?


The compound of a drug might exist in different polymorphic designs; nonetheless, any such designs will be subsumed inside the patent.

Subscribe to Read More.
Login Join Now